Effects of cisplatin-loaded niosomal nanoparticleson BT-20 human breast carcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 18, Issue 2, 2017, Pages 365-368

  Kanaani, Leila ^a   Javadi, Iraj ^a   Ebrahimifar, Meysam ^a   shahmabadi, Hasan Ebrahimi ^b   Khiyavi, Azim Akbarzadeh ^c   Mehrdiba, Torkan ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Breast cancer; Cisplatin; Cytotoxicity; MTT; Niosome nanoparticles

Indexed keywords

EID: 85016514690     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.22034/APJCP.2017.18.2.365     Document Type: Article

References (15)

1. Babaei M, Ardjmand M, Akbarzadeh A, et al (2014). Efficacy comparison of nanoniosomal and pegylated nanoniosomal Cisplatin on A172 cell line. Tissue Eng Regen Med, 11, 350-54
2. Bayindir ZS, Besikci A, Yuksel N (2015). Paclitaxelloaded niosomes for intravenous administration: pharmacokineticsand tissue distribution in rats. Turk J Med Sci, 45, 1403-12
3. Blanco Eand Ferrari M (2014). Emerging nanotherapeutic strategies in breast cancer. The Breast, 23, 10-18
4. Hosseinian S,Khajavi Rad A, Hadjzadeh M, et al (2016). The protective effect of Nigella sativa against cisplatin-induced nephrotoxicity in rats. Avicenna J Phytomed, 6, 44-54
5. Kanamala M, Wilson WR, Yang M, Palmer BD, Wu Z (2016). Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. Biomaterials, 85, 152-67
6. Kowapradit J, Apirakaramwong A, Ngawhirunpat T, et al (2012). Methylated N-(4-N, N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Eur J Pharm Sci, 47, 359-66
7. Li M, Tang Z, Zhang Y, et al (2015). Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis. Acta biomaterialia, 18, 132-43
8. Mokhtari MJ, Akbarzadeh A, Hashemi M, et al (2012). Cisplatin induces down regulation of Bcl2 in T47D Breast cancer cell line. Adv Stud Biol, 4, 19-25
9. Mokhtari MJ, Akbarzadeh A, Hashemi M, et al (2012). Cisplatin Induces Up-Regulation of KAI1, a Metastasis Suppressor Gene, in MCF-7 Breast Cancer Cell Line. Trop J Pharm Res, 11, 523-29
10. Mujoriya R, Babu Bodla R (2012). Design and development of niosomal delivery system for Ketoprofen. available at htpp://hdl. net/123456789/97, 2012
11. Ostad SN, Dehnad S, Esmail Nazari Z, et al (2010). Cytotoxic activities of silver nanoparticles and silver ions in parent and tamoxifen-resistant T47D human breast cancer cells and their combination effects with tamoxifen against resistant cells. Avicenna J Med Biotechnol, 2, 187-96
12. Pawar S, Shevalkar G, Vavia P (2016). Glucosamine anchored doxorubicin loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation. J Drug Target, 24, 730-43
13. Redig AJ, McAllister SS (2013). Breast cancer as a systemic disease: a view of metastasis. J Intern Med, 274, 113-26
14. Rajput S, Puvvada N, Kumar BNP, et al (2015). Overcoming akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes. Mol Pharmaceutics, 12, 4214-25
15. Shahbazian S, Akbarzadeh A, Torabi S, Omidi M (2015). Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D. Biotechnol Lett, 37, 1355-9